Wenjuan Wu

Lilly Research Laboratories Eli Lilly and Company

关注

立即认领

关注

立即认领

基本信息

浏览量：22

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure S1 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

Shripad V. Bhagwat,William T. McMillen,Shufen Cai,Baohui Zhao,Matthew Whitesell,Weihua Shen,Lisa Kindler,Robert S. Flack,Wenjuan Wu,Bryan Anderson, Yan Zhai,Xiu-Juan Yuan,Meghann Pogue,Robert D. Van Horn,Xi Rao,Denis McCann,Andrew J. Dropsey,Jason Manro,Jennie Walgren,Eunice Yuen,Michael J. Rodriguez,Gregory D. Plowman,Ramon V. Tiu,Sajan Joseph,Sheng-Bin Peng

openalex（2023）

引用0浏览0引用

Figure S4 from Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

Genshi Zhao,Colin F. Green,Yu-Hua Hui,Lourdes Prieto,Robert Shepard,Sucai Dong,Tao Wang,Bo Tan,Xueqian Gong,Lisa Kays,Robert L. Johnson,Wenjuan Wu,Shobha Bhattachar,Miriam Del Prado,James R. Gillig,Maria-Carmen Fernandez,Ken D. Roth,Sean Buchanan,Ming-Shang Kuo,Sandaruwan Geeganage,Timothy P. Burkholder

openalex（2023）

引用0浏览0引用

Supplementary Table S2 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

引用0浏览0引用

Supplementary Table S1 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

引用0浏览0引用

Figure S3 from Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

openalex（2023）

引用0浏览0引用

Figure S2 from Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

openalex（2023）

引用0浏览0引用

Supplementary Figure S4 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

引用0浏览0引用

Supplementary Figure S6 from ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

openalex（2023）

引用0浏览0引用

Figure S5 from Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

openalex（2023）

引用0浏览0引用

TableS1, Table S2, Supplementary Methods and Figure Legends from Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 56

#Citation: 599

H-Index: 12

G-Index: 22

Sociability: 6

Diversity: 2

Activity: 29

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn